Evelo Biosciences, Inc. EVLO
0.00 USD 0.00 (+0.00%)
At closeNov 9, 2026, 4:00 PM EST
0.0005 Day range 0.0005
0.0001 52-week range 0.0005
- YTD
- -80.00%
- 1 year
- -80.00%
News
defenseworld.net Stock Traders Buy Large Volume of Evelo Biosciences Put Options (NASDAQ:EVLO) Evelo Biosciences, Inc. (NASDAQ: EVLO - Get Free Report) was the recipient of unusually large options trading on Wednesday. Investors acquired 1,885 put options on the stock. This represents an…
defenseworld.net Head to Head Review: Evelo Biosciences (NASDAQ:EVLO) vs. Silverback Therapeutics (NASDAQ:SBTX) Profitability This table compares Silverback Therapeutics and Evelo Biosciences' net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Silverback…
defenseworld.net Evelo Biosciences Sees Unusually High Options Volume (NASDAQ:EVLO) Evelo Biosciences, Inc. (NASDAQ: EVLO - Get Free Report) was the target of unusually large options trading on Wednesday. Stock investors acquired 1,885 put options on the company. This represents an…
defenseworld.net Stock Traders Buy High Volume of Evelo Biosciences Put Options (NASDAQ:EVLO) Evelo Biosciences, Inc. (NASDAQ: EVLO - Get Free Report) was the target of some unusual options trading on Wednesday. Traders acquired 1,885 put options on the stock. This is an increase of 1,101%…
defenseworld.net Evelo Biosciences (NASDAQ:EVLO) vs. Vincerx Pharma (NASDAQ:VINC) Financial Analysis Insider and Institutional Ownership 44.0% of Vincerx Pharma shares are held by institutional investors. Comparatively, 0.3% of Evelo Biosciences shares are held by institutional investors. 15.6% of…
defenseworld.net Evelo Biosciences Sees Unusually High Options Volume (NASDAQ:EVLO) Evelo Biosciences, Inc. (NASDAQ: EVLO - Get Free Report) was the target of some unusual options trading activity on Wednesday. Stock investors acquired 1,885 put options on the company. This is an…
defenseworld.net Analyzing Evelo Biosciences (NASDAQ:EVLO) & Antibe Therapeutics (OTCMKTS:ATBPD) Valuation and Earnings This table compares Antibe Therapeutics and Evelo Biosciences"s gross revenue, earnings per share (EPS) and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per…
businesswire.com EVLO to Provide Dominion Energy With Safety Enhanced Energy Storage Systems MONTRÉAL--(BUSINESS WIRE)--EVLO Energy Storage Inc. (EVLO), a fully integrated battery energy storage systems (BESS) provider and wholly owned subsidiary of Hydro-Québec, announces a major…
benzinga.com Top 4 Health Care Stocks That May Rocket Higher This Month - Generation Bio (NASDAQ:GBIO), Evelo Biosciences (NASDAQ:EVLO) The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session 
zacks.com Evelo (EVLO) Drops 59% on Flunking Psoriasis Drug Study Evelo's (EVLO) EDP2939 fails to achieve the primary endpoint in a mid-stage for treating moderate psoriasis. The company decides to cease clinical development on the candidate.
benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2023 
benzinga.com Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent on a $5.0 million private placement for SciSparc.
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session 
proactiveinvestors.com Evelo Biosciences shares tank 46% after trial failure Evelo Biosciences' shares have tumbled 46% in premarket trading after the biotech firm revealed disappointing results in a phase II psoriasis trial for its next-generation drug, EDP2939. A resounding…
marketwatch.com Evelo Biosciences to review options after Phase 2 trial of psoriasis treatment fails to meet main goal Evelo Biosciences Inc. EVLO, -6.73% said Tuesday it's reviewing its strategic options and exploring partnerships after a Phase 2 study of a treatment for psoriasis failed to meet its main goal. “The…
globenewswire.com Evelo Biosciences Announces Top-Line Results From its Phase 2 Clinical Study with EDP2939 in Moderate Psoriasis - Primary endpoint was not achieved – - Company exploring strategic alternatives and partnering opportunities for EDP1815 and its SINTAX platform - CAMBRIDGE, Mass., Oct. 17, 2023 (GLOBE NEWSWIRE) --…
seekingalpha.com Evelo Biosciences: May Be Worth A Small, Highly Speculative Long Position Considering Upcoming Psoriasis Phase 2 Results Following recent cash raise, EVLO has enough (barely) cash to the next catalyst, phase 2 readout in psoriasis. The event is binary and can make or break the company. Prior failure of EVLO's platform…
globenewswire.com Evelo Biosciences Announces Second Quarter Financial Results and Recent Business Highlights – EDP2939 Phase 2 trial in moderate psoriasis fully enrolled with topline data expected early Q4 2023 – Completed $25.5 Million Private Placement – Restructured and reduced secured debt with Horizon…- benzinga.com Why Metropolitan Bank Holding Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) jumped 69% to $22.59 after the company announced it reached a settlement with the SEC.
- benzinga.com Scholastic, Matson, Digital World Acquisition And Other Big Stocks Moving Higher On Friday U.S. stocks traded higher, with the Dow Jones gaining around 90 points on Friday. Here are some big stocks recording gains in today’s session.
globenewswire.com Evelo Biosciences Closes $25.5 Million Private Placement Restructures and reduce s secured debt with Horizon Technology Finance Corporation Appoints two new members and decreases size of Board of Directors
globenewswire.com Evelo Biosciences Announces $25.5 Million Private Placement CAMBRIDGE, Mass., July 10, 2023 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a novel platform of orally delivered…
benzinga.com Why Cineverse Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Friday's Mid-Day Session Gainers Addentax Group Corp. (NASDAQ: ATXG) shares jumped 47.3% to $9.68. Addentax Group is launching automation of artificial intelligence internet operational tools project with top…
benzinga.com Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) shares jumped 105% to $0.2050 after the company signed a distribution agreement with Cardinal Health.
benzinga.com Why American Equity Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket Gainers
benzinga.com Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session Gainers Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares climbed 422% to $0.5572 after the company announced acquisition of Spyre Therapeutics and concurrent oversubscribed $210 million private…- benzinga.com Why ToughBuilt Industries Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session Gainers Advanced Health Intelligence Ltd. (NASDAQ: AHI) shares jumped 209.5% to $2.29 after the company signed a Letter of Intention with UAE-Based e-script medicine management company Pharmak…
- benzinga.com Why Surgalign Holdings Shares Are Trading Lower By Around 75%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Gainers Airspan Networks Holdings Inc. (NYSE: MIMO) shares gained 79.5% to $0.2740.
investorplace.com Why Is Evelo Biosciences (EVLO) Stock Up 51% Today? Evelo Biosciences (NASDAQ: EVLO ) stock is rising higher on Tuesday after the clinical-stage biotechnology company reached a new standstill agreement with Horizon Technology Finance (NASDAQ: HRZN )…- benzinga.com Why Cano Health Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket Gainers
zacks.com What Makes Evelo Biosciences, Inc. (EVLO) a New Buy Stock Evelo Biosciences, Inc. (EVLO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).- benzinga.com Why First Republic Bank Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session Gainers Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 268% to $3.42 after dropping around 8% on Thursday.
benzinga.com Why Hitek Global Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket Gainers- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 345 companies set new 52-week lows.
- benzinga.com Why Chipotle Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 105% to $0.1730 after the company issued a letter to shareholders.
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session - benzinga.com Stocks That Hit 52-Week Lows On Tuesday Tuesday's session saw 286 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 175 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 198 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday Thursday's session saw 337 companies set new 52-week lows.
- benzinga.com Earnings Scheduled For March 16, 2023 Companies Reporting Before The Bell • KVH Industries (NASDAQ:KVHI) is projected to report quarterly earnings at $0.03 per share on revenue of $34.29 million.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 479 stocks made new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 497 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 100 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 135 companies reached new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 29 stocks made new 52-week lows.
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2022 Upgrades
- benzinga.com Why Amazon Shares Traded Lower; Here Are 74 Biggest Movers From Yesterday Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 72.8% to close at $2.16 on Monday as the stock continued to see momentum despite the company last week announcing it is not aware of…